NYSE ยท Healthcare ยท Drug Manufacturers - General
Market Cap$116.40B
SectorHealthcare
IndustryDrug Manufacturers - General
52-Week Low$42.52
52-Week High$62.89
CEOChristopher S. Boerner
IPO DateJun 1, 1972
Employees34,100
CountryUnited States
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis.